Soleus Capital Management, L.P. Aadi Bioscience, Inc. Transaction History
Soleus Capital Management, L.P.
- $1.18 Billion
- Q3 2024
A detailed history of Soleus Capital Management, L.P. transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 333,227 shares of AADI stock, worth $953,029. This represents 0.06% of its overall portfolio holdings.
Number of Shares
333,227
Previous 333,227
-0.0%
Holding current value
$953,029
Previous $486,000
41.15%
% of portfolio
0.06%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding AADI
# of Institutions
55Shares Held
12.6MCall Options Held
23.8KPut Options Held
0-
Avoro Capital Advisors LLC New York, NY2.85MShares$8.15 Million0.09% of portfolio
-
Bml Capital Management, LLC Zionsville, IN2MShares$5.72 Million2.42% of portfolio
-
Acuta Capital Partners, LLC Belmont, CA1.85MShares$5.29 Million3.86% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA1.85MShares$5.28 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA766KShares$2.19 Million0.0% of portfolio
About Aadi Bioscience, Inc.
- Ticker AADI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,016,800
- Market Cap $60.1M
- Description
- Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...